Pharmena (WAR:PHR) Other Current Payables: zł0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:PHR Pharmena SA WAR:PHR
53 GF Score
Price zł3.17
GF Value zł5.68
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Pharmena Other Current Payables?

Pharmena WAR:PHR +2.26% 53 Other Current Payables is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:PHR with a GF Score™ of 53/100 and a GF Value™ of zł5.68 (Possible Value Trap). The stock has 4 warning signs investors should review.

Pharmena's Other Current Payables for the quarter that ended in Mar. 2026 was zł0.00 Mil.

Pharmena's annual Other Current Payables increased from Dec. 2023 (zł-0.00 Mil) to Dec. 2024 (zł0.00 Mil) but then stayed the same from Dec. 2024 (zł0.00 Mil) to Dec. 2025 (zł0.00 Mil).

Pharmena Other Current Payables Related Terms

Pharmena Other Current Payables Historical Data

* Premium members only.

The historical data trend for Pharmena's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmena Other Current Payables Chart

Pharmena Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.83 0.00 -0.00 0.00 0.00

Pharmena Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:PHR
53GF Score
Pharmena SA WAR:PHR
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmena Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of zł0.00 Mil mean?
Pharmena (WAR:PHR) has a Other Current Payables of zł0.00 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pharmena and its competitors.
Is Pharmena's Other Current Payables too high?
Pharmena's current Other Current Payables is zł0.00 Mil. Overall, Pharmena has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharmena's Other Current Payables compare to VRTX and REGN?
Pharmena's Other Current Payables of zł0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pharmena and its competitors. Pharmena's current Other Current Payables is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmena stock overvalued right now?
Based on GuruFocus' analysis, Pharmena (WAR:PHR) is currently considered Possible Value Trap. The stock's GF Value™ is zł5.68, compared to a current price of zł3.17 — trading 44.2% below its estimated fair value. The current Other Current Payables is zł0.00 Mil. Pharmena's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Pharmena (WAR:PHR), the current Other Current Payables is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmena (WAR:PHR) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmena stock appears to be undervalued. The current stock price of zł3.17 is trading 44.2% below its estimated GF Value™ of zł5.68. GuruFocus considers Pharmena to be Possible Value Trap.

Key valuation signals for WAR:PHR:

  • Other Current Payables: zł0.00 Mil
  • GF Value™: zł5.68 vs. price of zł3.17 (44.2% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the WAR:PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmena Business Description

Address Ulica Wolczanska 178, Lodz, POL, 90-530
Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.
53GF Score

Get the complete analysis for WAR:PHR

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł3.17
Price
zł5.68
GF Value